The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InIn a move aimed at restructuring its industrial business model, Valmet's Board of Directors has announced a strategic review to evaluate a potential separation of its two core business segments into independent companies listed on Nasdaq Helsinki. According to reports, the review will assess splitting "Biomaterial Solutions and Services" and "Process Performance Solutions" into standalone entities following the completion of the Severn acquisition, which bolstered the latter's sales. This initiative seeks to enable each business to better realize its full potential and unlock long-term value for shareholders.
The review comes as Valmet has undergone a significant transformation over the past decade, evolving from a primary focus on pulp and paper into a diversified industrial platform that generated nearly 70% of its net sales from other industries in 2025, totaling approximately EUR 5.2 billion. Per market dynamics, this shift reflects the company's desire to leverage its recently established operating model while maintaining market leadership in automation, flow control, and sustainable energy technologies.
Operationally, Valmet intends to provide an update on the strategic review's progress no later than the publication of its full-year 2026 financial results. Looking at broader economic indicators, investors in European markets are monitoring inflation trends, as EU CPI data released on July 17, 2026, showed a steady 2.8% year-on-year increase, providing a relatively stable backdrop for major corporate restructuring plans.